Compare RELL & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RELL | PALI |
|---|---|---|
| Founded | 1947 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.1M | 249.2M |
| IPO Year | 2004 | 2019 |
| Metric | RELL | PALI |
|---|---|---|
| Price | $19.92 | $1.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | ★ $25.50 | $9.80 |
| AVG Volume (30 Days) | 342.9K | ★ 2.8M |
| Earning Date | 10-07-2026 | 11-13-2026 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $228,564,000.00 | $260,000.00 |
| Revenue This Year | $12.68 | N/A |
| Revenue Next Year | $9.21 | N/A |
| P/E Ratio | $230.96 | ★ N/A |
| Revenue Growth | 9.41 | ★ 1500.39 |
| 52 Week Low | $9.37 | $1.10 |
| 52 Week High | $23.15 | $2.86 |
| Indicator | RELL | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 30.77 |
| Support Level | $15.83 | N/A |
| Resistance Level | $21.62 | $2.19 |
| Average True Range (ATR) | 1.15 | 0.11 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 66.15 | 16.70 |
Richardson Electronics Ltd is a world-wide manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions. It serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. Its products and services include design-in support, systems integration, prototype design and manufacturing, testing, logistics, etc. Its segments are Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. Majority of Sales is from PMT. Majority of sales is from North America.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.